As the global pandemic continues in many countries across the world, people who use drugs face more marginalisation and stigma than ever before. With many resources re-directed to COVID-19, there are also significant challenges in accessing testing and treatment for hepatitis C and other infectious diseases.
It is for this reason that we believe the 2021 INHSU Conference is one of the most important we will hold to date. Our global network feels it is vital to continue to facilitate knowledge exchange now more than ever.
Australia has been fortunate to have fared well during the pandemic; many services pivoted quickly and adapted the way they operated due to COVID-19, and in many areas HCV and other services are now back up and running. There is enthusiasm in the Australian community to share these learnings whilst turning the spotlight back onto HCV and other infectious diseases.
2020 was a year of resilience in the face of adversity for many in our network. It highlighted the strength of our global community and reaffirmed the ongoing need for knowledge sharing and collaborations.
With all of this in mind – and after careful consideration and global consultation with key opinion leaders – we are delighted to announce that the 9th International Conference on Health and Hepatitis Care in Substance Users will take place in Australia, via a hybrid delivery model.
For those who can travel, we will be holding a face-to-face event. For those who are unable to travel, we will be hosting selected conference sessions virtually, via a state-of-the art virtual platform. These will be available both live and on-demand, ensuring the same learning opportunities no matter where you are in the world.
We hope you will join us and we look forward to seeing you in person or online in October.
- Jason Grebely, INHSU President